ArticleTheranostics2025
Ultrasound-activated erythrocyte membrane-camouflaged Pt (II) layered double hydroxide enhances PD-1 inhibitor efficacy in triple-negative breast cancer through cGAS-STING pathway-mediated immunogenic cell death.
Abstract read
In one paragraph
Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- An endoplasmic reticulum-enriched nanogel couples ferroptotic tumor damage with macrophage reprogramming for triple-negative breast cancer immunotherapy.Bioactive materials · 2027Article
- Advances in research on layered double hydroxides for biomedical applications.Smart molecules : open access · 2026Review
- A Self-Immunoregulatory Nanosensitizer for Sonodynamic Cancer Therapy.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- A biomimetic nanointegrator synergizing "dual-throttle" immune checkpoint blockade and enhanced DAMPs-mediated immune activation for potent anti-tumor T‑cell immunity.Journal of nanobiotechnology · 2026Article
- Metal-dependent regulated cell death: Molecular architecture and translational frontiers.iMeta · 2026Review
- Endoplasmic Reticulum-Targeting NIR Cyanine ER800 Nanoparticles Promote Pyroptosis in Triple-Negative Breast Cancer.ACS applied materials & interfaces · 2026Article
- Sonodynamic Therapy-Enhanced Immunotherapy for Triple-Negative Breast Cancer: Mechanistic Advances, Nanoplatform Strategies, and Clinical Prospects.Molecular imaging and biology · 2026Review
- Leveraging the crosstalk between cGAS-STING and pyroptosis by nanomedicine to enhance antitumor immunity.Journal of nanobiotechnology · 2026Review
- Advances in NP shapes and their applications in cancer therapy.RSC advances · 2026Review
- The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy.Molecular cancer · 2026Review
- NK cell biomimetic MOF nanoplatform disrupts hypoxia adaption for complete tumor ablation.Journal of nanobiotechnology · 2026Article
- Albumin-bound paclitaxel drives a cytotoxic CD8Frontiers in immunology · 2026Article
- Decoding the molecular mechanisms of pyroptosis and its therapeutic development prospects.Frontiers in cell and developmental biology · 2026Review
- 2D nanomaterial-triggered ferroptosis in cancer therapy.Journal of nanobiotechnology · 2025Review
- Mitochondrial Quality Control and Cell Death.International journal of molecular sciences · 2025Review
- Bioactive LDH nanoplatforms for cancer therapy: Advances in modulating programmed cell death.Materials today. Bio · 2025Review
- Nanosensitizer-assisted sonodynamic therapy for breast cancer.Journal of nanobiotechnology · 2025Review
- Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy.Theranostics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Yanjie WuSchool of Science and Engineering, Shenzhen Key Laboratory of Innovative Drug Synthesis, The Chinese University of Hong Kong, Shenzhen, 518172, China.
Zhiyu ZhaoCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Mengli MaCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Weijin ZhangCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Wei LiuThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510026, China.
Xiaochen LiangEnvironmental Toxicology, University of California, Riverside, CA, 92507, USA.
Ting ZhaoEnvironmental Toxicology, University of California, Riverside, CA, 92507, USA.
Yi LuoInstitute of Immunotherapy, School of Basic Medicine, Fujian Medical University, Fuzhou, 350122, China.
Yunjie WangCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Mengqi LiCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Tingting LiDepartment of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Cong LiuDepartment of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Xian LuoCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Shengyu WangCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Wanyun LiCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Wei ZengDepartment of Gastroenterology, Department of Obstetrics and Gynecology, Affiliated Xiang'an Hospital, Medical Center, Xiamen University, 361000, China.
Hong WangDepartment of Gastroenterology, Department of Obstetrics and Gynecology, Affiliated Xiang'an Hospital, Medical Center, Xiamen University, 361000, China.
Wengang LiCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Ting WuCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Zhihai KeSchool of Science and Engineering, Shenzhen Key Laboratory of Innovative Drug Synthesis, The Chinese University of Hong Kong, Shenzhen, 518172, China.
Fanghong LuoCancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Erythrocyte MembraneHydroxidesImmune Checkpoint InhibitorsImmunogenic Cell DeathPlatinumTriple Negative Breast NeoplasmsAnimalsCell Line, TumorCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseFemaleHumansMembrane ProteinsMiceMice, Inbred BALB CNucleotidyltransferasesProgrammed Cell Death 1 ReceptorcGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseHydroxidesImmune Checkpoint InhibitorsMembrane ProteinsNucleotidyltransferasesPlatinumProgrammed Cell Death 1 ReceptorSTING1 protein, humanSTING ProteinBreast CancerFerroptosisImmunogenic cell deathLayered double hydroxides (LDHs)Pyroptosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.